Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells. Issue 8 (21st June 2021)
- Record Type:
- Journal Article
- Title:
- Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells. Issue 8 (21st June 2021)
- Main Title:
- Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells
- Authors:
- Manfredi, Francesco
Abbati, Danilo
Cianciotti, Beatrice Claudia
Stasi, Lorena
Potenza, Alessia
Ruggiero, Eliana
Magnani, Zulma
Carnevale, Erica
Doglio, Matteo
Noviello, Maddalena
Tassi, Elena
Balestrieri, Chiara
Buonanno, Silvia
Clemente, Francesca
De Lalla, Claudia
Protti, Maria Pia
Mondino, Anna
Casorati, Giulia
Dellabona, Paolo
Bonini, Chiara - Abstract:
- Abstract: The phenotype of infused cells is a major determinant of Adoptive T‐cell therapy (ACT) efficacy. Yet, the difficulty in deciphering multiparametric cytometry data limited the fine characterization of cellular products. To allow the analysis of dynamic and complex flow cytometry samples, we developed cytoChain, a novel dataset mining tool and a new analytical workflow. CytoChain was challenged to compare state‐of‐the‐art and innovative culture conditions to generate stem‐like memory cells (TSCM ) suitable for ACT. Noticeably, the combination of IL‐7/15 and superoxides scavenging sustained the emergence of a previously unidentified nonexhausted Fit‐TSCM signature, overlooked by manual gating and endowed with superior expansion potential. CytoChain proficiently traced back this population in independent datasets, and in T‐cell receptor engineered lymphocytes. CytoChain flexibility and function were then further validated on a published dataset from circulating T cells in COVID‐19 patients. Collectively, our results support the use of cytoChain to identify novel, functionally critical immunophenotypes for ACT and patients immunomonitoring. Abstract : Exploring TCR‐engineered T cells interactions with cytoChain entails superior data mining. CytoChain is a novel workflow and application able to underline qualitative differences missed by both manual gating or canonical high‐dimensional analysis. Its utilization underlined the effects of various supplements upon T‐cellAbstract: The phenotype of infused cells is a major determinant of Adoptive T‐cell therapy (ACT) efficacy. Yet, the difficulty in deciphering multiparametric cytometry data limited the fine characterization of cellular products. To allow the analysis of dynamic and complex flow cytometry samples, we developed cytoChain, a novel dataset mining tool and a new analytical workflow. CytoChain was challenged to compare state‐of‐the‐art and innovative culture conditions to generate stem‐like memory cells (TSCM ) suitable for ACT. Noticeably, the combination of IL‐7/15 and superoxides scavenging sustained the emergence of a previously unidentified nonexhausted Fit‐TSCM signature, overlooked by manual gating and endowed with superior expansion potential. CytoChain proficiently traced back this population in independent datasets, and in T‐cell receptor engineered lymphocytes. CytoChain flexibility and function were then further validated on a published dataset from circulating T cells in COVID‐19 patients. Collectively, our results support the use of cytoChain to identify novel, functionally critical immunophenotypes for ACT and patients immunomonitoring. Abstract : Exploring TCR‐engineered T cells interactions with cytoChain entails superior data mining. CytoChain is a novel workflow and application able to underline qualitative differences missed by both manual gating or canonical high‐dimensional analysis. Its utilization underlined the effects of various supplements upon T‐cell Receptor gene editing, and the T cell changes developing in COVID‐19 patients according to disease severity. … (more)
- Is Part Of:
- European journal of immunology. Volume 51:Issue 8(2021)
- Journal:
- European journal of immunology
- Issue:
- Volume 51:Issue 8(2021)
- Issue Display:
- Volume 51, Issue 8 (2021)
- Year:
- 2021
- Volume:
- 51
- Issue:
- 8
- Issue Sort Value:
- 2021-0051-0008-0000
- Page Start:
- 1992
- Page End:
- 2005
- Publication Date:
- 2021-06-21
- Subjects:
- Adoptive T‐cell therapy -- COVID‐19 -- Flow Cytometry -- High‐dimensional analysis -- Immune exhaustion
Immunology -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/eji.202049103 ↗
- Languages:
- English
- ISSNs:
- 0014-2980
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.730100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26356.xml